Innovative Models in the Rehabilitation of the Elderly With Hip Fractures

Status Recruiting

Clinical Trial Summary

The final goals of the present study is to propose a new approach in the hip fracture rehabilitation in elderly subjects, focused on the use of robotic device and to check the results not only at the end of the treatment but also in the long term, foreseeing 3 follow-up.

Clinical Trial Description

Balance and deficit in walking are some of the main characteristics of aging and are considered among the risk factors for falls. Falls are a risk factor for future falls and are associated with other adverse health outcomes such as fear of falling or fractures. In particular, hip fracture in aged patients is an important health problem. In fact, one in three patients dies within the first year after injury, while survivors have poor quality of life For this reason, the development of prevention tools and innovative strategies in the rehabilitation field should be one of the main objectives in the treatment of the diseases afflicting the elderly, such as hip fractures. Effective interventions to promote hip recovery post hip fracture are characterized by intensive and repetitive movements. One treatment approach to increase number of steps during rehabilitation sessions and to improve the balance and the endurance of the patients is the use of robotic systems. This study is a randomized controlled trial. A total of 195 patients with hip fractures will be recruited and randomly divided into three groups, to receive a traditional rehabilitation program or a robotic rehabilitation in addition to the traditional therapy. Assessments will be performed at baseline, at the end of treatment and 6 months, 1 year and 2 years from the end of the treatment. For the study, post-hospitalization subjects will be taken into consideration, after four weeks from the hospitalization. A 20 treatment sessions will be conducted, divided into 3 training sessions per week, for 7 weeks. The control group will perform traditional therapy sessions lasting 50 minutes. The technological intervention group will carry out 30 minutes of traditional therapy and 20 minutes of treatment with a robotic system. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04095338
Study type	Interventional
Source	Istituto Nazionale di Ricovero e Cura per Anziani
Contact	Roberta Bevilacqua
Phone	00390718004767
Email	r.bevilacqua@inrca.it
Status	Recruiting
Phase	N/A
Start date	November 26, 2019
Completion date	March 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02507609` - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium	N/A
Completed	`NCT03906864` - Care Pathway for Sub-acute Hip Rehabilitation	N/A
Recruiting	`NCT04063891` - Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients	N/A
Completed	`NCT05039879` - Life Improving Factors After a Hip Fracture
Not yet recruiting	`NCT03887494` - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY)	N/A
Terminated	`NCT03065101` - Trigen InterTAN vs Sliding Hip Screw RCT	N/A
Completed	`NCT03695081` - Patient Pathway Pharmacist - Optimal Drug-related Care	N/A
Completed	`NCT03545347` - Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.	Phase 2
Recruiting	`NCT05971173` - Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery	Early Phase 1
Active, not recruiting	`NCT04957251` - Anterior vs Posterior Approach for Hip Hemiarthroplasty	N/A
Terminated	`NCT04372966` - Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures	N/A
Withdrawn	`NCT05030688` - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty	N/A
Completed	`NCT04424186` - 'Rehabilitation for Life'	N/A
Not yet recruiting	`NCT04183075` - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture	N/A
Withdrawn	`NCT05518279` - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures	Phase 3
Not yet recruiting	`NCT02892968` - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients	N/A
Not yet recruiting	`NCT02223572` - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture	N/A
Active, not recruiting	`NCT02247791` - Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty	N/A
Completed	`NCT00746876` - Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures.	N/A
Completed	`NCT00058864` - The HIP Impact Protection Program (HIP PRO)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Innovative Models in the Rehabilitation of the Elderly With Hip Fractures Through Technological Innovation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms